MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
86.57%
Quick Ratio
86.57%
Cash Ratio
8.23%
Debt to Asset Ratio
115.33%
Unit: Dollar
Assets Breakdown
    • Prepaid expenses and other
    • Digital assets at fair value
    • Cash and cash equivalents
    • Equipment, net
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
196,325
1,691,043
5,536,955
6,308,420
Prepaid expenses and other
1,398,024
247,363
133,919
278,342
Digital assets at fair value
472,003
-
-
-
Total current assets
2,066,352
1,938,406
5,670,874
6,586,762
Digital assets at fair value
-
1,585,356
1,145,180
-
Prepaid expenses
-
993,701
993,701
993,701
Equipment, net
3,210
3,511
3,812
4,113
Total assets
2,069,562
4,520,974
7,813,567
7,584,576
Accounts payable
1,659,438
840,370
1,056,796
727,172
Accrued expenses
727,465
1,139,723
1,179,457
1,023,806
Total current liabilities
2,386,903
1,980,093
2,236,253
1,750,978
Total liabilities
2,386,903
1,980,093
2,236,253
1,750,978
Common stock, par value 0.0001, 1,000,000,000 shares authorized 2,793,386 issued and outstanding at june 30, 2026 2,572,114 issued and 2,571,914 outstanding at december 31, 2025
279
269
257
5,287
Additional paid-in capital
107,108,086
106,700,824
106,660,090
103,552,406
Treasury stock, 200 shares at cost
-
-
300,000
300,000
Accumulated deficit
-107,425,706
-104,160,212
-100,783,033
-97,424,095
Total stockholders (deficit) equity
-317,341
2,540,881
5,577,314
5,833,598
Total liabilities and stockholders (deficit) equity
2,069,562
4,520,974
7,813,567
7,584,576
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses andother$1,398,024 (543.65%↑ Y/Y)Digital assets at fairvalue$472,003 Cash and cashequivalents$196,325 (-97.17%↓ Y/Y)Total current assets$2,066,352 (-71.12%↓ Y/Y)Equipment, net$3,210 Total assets$2,069,562 (-74.71%↓ Y/Y)Accumulated deficit-$107,425,706 (-14.30%↓ Y/Y)Total liabilities andstockholders (deficit)...$2,069,562 (-74.71%↓ Y/Y)Total stockholders(deficit) equity-$317,341 (-105.20%↓ Y/Y)Additional paid-in capital$107,108,086 (6.69%↑ Y/Y)Common stock, par value0.0001, 1,000,000,000...$279 (-93.08%↓ Y/Y)Total liabilities$2,386,903 (15.05%↑ Y/Y)Total currentliabilities$2,386,903 (15.05%↑ Y/Y)Accounts payable$1,659,438 (111.19%↑ Y/Y)Accrued expenses$727,465 (-42.41%↓ Y/Y)

Processa Pharmaceuticals, Inc. (PCSA)

Processa Pharmaceuticals, Inc. (PCSA)